Clinical Trial Update: A Combination Study of CAR-T Therapy in r/r B-NHL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on a CAR-T therapy for relapsed/refractory B-cell non-Hodgkin lymphoma, specifically diffuse large B-cell lymphoma (DLBCL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN